API | y90 humanized anti-tac

y90 humanized anti-tac Report issue

Biologics mAb Experimental

AACT ChEMBL

Active Ingredient History

NOW

Chemistry

SMILES: Missing data
InChIKey: Missing data
Mol. Mass: Missing data
ALogP: Missing data
ChEMBL Molecule:
anti-tac 90 y-hat

More Chemistry

Pharmacology

Mechanisms of Action:
- Interleukin-2 receptor subunit alpha (Homo sapiens) ^UniProt
- Peripheral myelin protein 22 (Rattus norvegicus) ^UniProt
Multi-specific: No
Payload: 90-Yttrium
Black Box: No
Availability: Missing data
Delivery Methods: Missing data
Pro Drug: No

anti-tac 90 y-hat | y90 humanized anti-tac | y90 radiolabeled anti-tac antibody

Organizations (2)

Research & Development (2)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Marketing (0)

Organization	Org Type	FDA approvals	Clinical Trials involvement	Org ID	Force Sort

Indications (4)

Approved Indications (0)

Experimental Indications - Clinical Trial Phases 1-4 (4)

Hodgkin Disease (Phase 1/Phase 2)

Leukemia, T-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 1/Phase 2)

Lymphoma, T-Cell, Cutaneous (Phase 1)

Overview

Highest Phase: Phase 2
# of Trials: 2
# of Trial Organizations: 2

Trials by Phase

Trial	Phase	Start Date	Organizations	Indications

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue